Drug Profile
Research programme: non-nucleoside reverse transcriptase inhibitors - GlaxoSmithKline
Alternative Names: 678248; GSK 3968A; GSK3986A; GW 3011; GW 4511; GW 4751; GW 8248; GW 8248X; GW 8635Latest Information Update: 19 Apr 2011
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Amides; Benzophenones
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 21 Aug 2008 Pharmacodynamics and pharmacokinetics data from a preclinical trial in HIV infections presented at the 236th American Chemical Society National Meeting (236th-ACS-2008)
- 28 Jul 2003 Data presented at the 2nd IAS Conference on HIV Pathogenesis and Treatment (IAS-2003) have been added to the Viral infections pharmacodynamics section ,
- 06 May 2003 Data presented at the 16th International Conference on Antiviral Research (ICAR-2003) have been added to the Viral infections therapeutic trials section